[Bacterial meningitis in the newborn].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D004927:Escherichia coli Infections / Q000382:microbiology; D005260:Female; D005865:Gestational Age; D006801:Humans; D006814:Hungary; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000382:microbiology*; D007235:Infant, Premature, Diseases / Q000209:etiology; D008607:Intellectual Disability / Q000209:etiology; D007710:Klebsiella Infections / Q000382:microbiology; D008431:Maternal-Fetal Exchange; D008581:Meningitis / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology* / Q000401:mortality; D009461:Neurologic Manifestations; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D011512:Proteus Infections / Q000382:microbiology; D011552:Pseudomonas Infections / Q000382:microbiology; D013203:Staphylococcal Infections / Q000382:microbiology
D000900:Anti-Bacterial Agents
Uber die bakterielle Meningitis bei Neugeborenen